object
review
avail
literatur
associ
acut
viral
respiratori
tract
infect
onset
asthma
exacerb
identifi
preval
virus
detect
method
well
prevent
therapeut
aspect
sourc
search
conduct
pubm
lilac
scielo
databas
year
use
follow
descriptor
asthma
exacerb
viru
child
acut
respiratori
infect
summari
find
total
origin
articl
address
identif
respiratori
virus
episod
asthma
exacerb
select
mostli
crosssect
studi
wide
variat
methodolog
assess
studi
particularli
relat
children
age
method
collect
viral
detect
result
indic
exacerb
viral
agent
potenti
main
trigger
factor
human
rhinoviru
frequent
identifi
factor
pattern
viral
circul
may
respons
season
exacerb
associ
viral
infect
allerg
inflamm
appear
crucial
clinic
function
uncontrol
asthma
studi
evalu
trigger
factor
associ
viral
infect
conclus
respiratori
virus
present
major
asthmat
children
episod
exacerb
involv
physiopatholog
mechan
yet
fulli
establish
synerg
allerg
inflamm
viral
infect
appear
determin
uncontrol
diseas
role
trigger
protect
agent
yet
clearli
determin
pleas
cite
articl
costa
ld
costa
ps
camargo
pa
exacerb
asthma
airway
infect
viru
villain
j
pediatr
rio
j
studi
conduct
trato
da
asma
e
da
via
objetivo
rever
literatura
sobr
entr
viral
aguda
trato
e
desencadeamento
de
da
asma
identificando
os
mai
prevalent
os
de
bem
como
os
aspecto
preventivo
e
font
do
dado
foi
realizada
uma
busca
na
base
de
dado
pubm
scielo
e
lilac
utilizando
os
descritor
asma
e
aguda
entr
os
ano
de
e
do
dado
foram
selecionado
artigo
originai
que
tratavam
da
de
durant
de
da
asma
em
sua
maioria
estudo
transversai
houv
ampla
na
metodologia
do
trabalho
avaliado
principalment
em
idad
da
e
de
coleta
e
viral
os
resultado
apontam
que
em
da
um
agent
viral
foi
potencialment
princip
fator
desencadeant
sendo
humano
mai
identificado
de
viral
pode
ter
sido
pela
sazonalidad
da
entr
viral
e
parec
ser
determinant
para
levar
ao
descontrol
da
asma
pouco
estudo
avaliaram
outro
fator
desencadeant
em
com
viral
os
present
na
maioria
da
durant
os
de
os
mecanismo
envolvido
ainda
totalment
estabelecido
e
sinergismo
entr
e
viral
parec
determinar
descontrol
da
papel
do
outro
agent
desencadeant
e
protetor
clarament
determinado
asthma
chronic
geneticallydetermin
diseas
whose
preval
pediatr
popul
rang
among
brazilian
adolesc
schoolchildren
respect
physiopatholog
viewpoint
character
chronic
inflamm
involv
sever
cell
type
associ
airway
hyperrespons
episod
revers
airflow
limit
clinic
manifest
recurr
exacerb
also
call
asthma
attack
appropri
acut
asthma
character
progress
worsen
dyspnea
cough
wheez
chest
tight
combin
loss
clinic
function
asthma
control
usual
occur
gradual
occur
abruptli
subgroup
patient
one
main
caus
emerg
consult
respons
death
children
younger
year
brazil
public
polici
develop
promot
scientif
knowledg
diseas
manag
well
organ
assist
program
public
health
includ
among
other
dispens
medic
howev
exacerb
continu
repres
signific
number
statist
great
impact
public
privat
healthcar
system
multifactori
origin
clinicalfunct
lack
diseas
control
well
known
sinc
earli
respiratori
virus
associ
trigger
asthma
exacerb
adult
children
develop
sensit
specif
molecular
techniqu
allow
increas
respiratori
viru
detect
therefor
way
better
explain
associ
studi
use
revers
transcriptas
polymeras
chain
reaction
rtpcr
detect
techniqu
isol
combin
tradit
method
observ
posit
respiratori
virus
episod
acut
asthma
exacerb
children
consid
possibl
causal
relationship
respiratori
viru
infect
trigger
asthma
attack
children
implic
associ
well
possibl
specif
prophylaxi
therapi
agent
special
attent
subject
justifi
therefor
literatur
review
aim
analyz
articl
publish
assess
associ
asthma
exacerb
acut
viral
airway
infect
search
conduct
pubm
lilac
scielo
databas
use
descriptor
asthma
exacerb
viral
infect
child
result
total
refer
period
select
articl
publish
portugues
english
spanish
french
articl
remain
read
titl
abstract
origin
articl
assess
respiratori
tract
viral
infect
asthmat
children
exacerb
select
articl
histor
import
review
articl
includ
three
descriptor
ad
gener
bibliographi
review
list
refer
insert
endnot
thompson
corp
ca
usa
bibliograph
citat
manag
softwar
frequent
identifi
respiratori
virus
associ
asthma
exacerb
human
rhinoviru
hrv
respiratori
syncyti
viru
rsv
human
adenoviru
hadv
influenza
flu
parainfluenza
pflu
human
metapneumoviru
hmpv
human
coronaviru
hcov
list
virus
rna
nucleic
acid
biolog
characterist
taxonomi
describ
tabl
main
transmiss
method
virus
contamin
fomit
droplet
aerosol
direct
contamin
infect
nasal
epithelium
cell
agent
trigger
immun
respons
involv
mainli
dendrit
cell
natur
killer
nk
cell
induc
releas
number
proinflammatori
cytokin
chemokin
infect
epitheli
cell
interferon
tumor
necrosi
factor
alpha
among
other
fig
asthma
patient
viral
infect
caus
imbal
immun
homeostasi
respiratori
system
sever
mechan
relat
viral
infect
allerg
inflamm
well
role
trigger
acut
asthma
propos
among
defici
function
epitheli
barrier
caus
viru
implic
predispos
factor
howev
asthma
atopi
associ
epitheli
damag
may
contribut
increas
suscept
infect
includ
viral
diseas
sensit
aeroallergen
anoth
evalu
factor
mucu
product
airway
defens
mechan
mice
studi
demonstr
allerg
inflamm
viral
infect
act
synergist
increas
mucu
product
lead
airway
impact
obstruct
asthma
patient
virusinduc
alter
interferon
product
also
observ
instanc
vivo
vitro
studi
epitheli
cell
healthi
adult
asthma
patient
infect
hrv
demonstr
decreas
product
type
interferon
latter
make
suscept
infect
associ
viral
exacerb
similar
result
obtain
studi
perform
children
product
interferon
cytokin
bronchial
epitheli
cell
assess
infect
lower
interferon
product
higher
concentr
viral
rna
demonstr
children
asthma
regardless
atop
statu
atop
children
without
asthma
suggest
impair
immun
respons
viral
infect
occur
asthma
patient
children
disord
associ
lymphocyt
howev
studi
fail
demonstr
reduct
interferon
product
other
even
found
increas
product
exacerb
asthma
bronchial
epithelium
produc
cytokin
includ
interleukin
well
thymic
stromal
lymphopoietin
promot
differenti
innat
lymphoid
cell
latter
induc
viral
infect
product
increas
suggest
interact
virus
allerg
airway
inflamm
may
enhanc
inflammatori
respons
potenti
reduc
antivir
respons
collect
viral
detect
method
viral
detect
highli
depend
qualiti
collect
sampl
time
symptom
onset
time
collect
ideal
within
hour
transport
storag
sampl
test
analysi
respiratori
virus
perform
materi
airway
upper
airway
secret
use
case
sever
method
employ
collect
nasopharyng
aspir
npa
nasopharyng
swab
np
nasopharyng
lavag
combin
nasalor
swab
first
techniqu
consid
gold
standard
recent
new
flock
swab
copan
brescia
itali
develop
present
better
perform
data
collect
recent
studi
use
type
swab
present
sensit
compar
npa
detect
perform
pcr
suggest
swab
use
epidemiolog
research
surveil
studi
due
greater
technic
simplic
data
support
use
combin
oralnas
swab
viru
detect
sensit
lower
nasopharyng
swab
aspir
explain
lower
viral
load
oropharynx
nasopharynx
collect
also
perform
materi
lower
airway
induc
sputum
bronchial
lavag
method
detect
respiratori
virus
vari
includ
rapid
test
antigen
detect
cultur
direct
indirect
immunofluoresc
nucleic
acid
amplif
reaction
rtpcr
detect
singl
agent
monoplex
perform
multipl
detect
multiplex
sensit
latter
higher
use
recent
studi
immunofluoresc
reaction
lower
cost
faster
perform
also
abl
detect
multipl
virus
panel
seven
virus
iflu
b
pflu
hadv
rsv
gener
use
virus
hrv
bocaviru
detect
nucleic
acid
amplif
reaction
sever
author
perform
studi
aim
detect
virus
respiratori
secret
exacerb
asthma
patient
show
preval
viral
identif
vari
sever
factor
patient
age
time
year
method
sampl
collect
method
viral
detect
tabl
present
origin
articl
demonstr
result
viral
test
children
exacerb
asthma
studi
found
preval
rate
case
frequent
identifi
viru
hrv
investig
respiratori
virus
children
age
three
year
hospit
asthma
exacerb
perform
period
month
bueno
air
argentina
due
possibl
diagnos
wheez
episod
infant
definit
immun
process
involv
respons
respiratori
virus
associ
allerg
inflamm
respiratori
virus
infect
bronchial
epitheli
cell
bec
toollik
receptor
tlr
replic
trigger
inflammatori
process
induct
cytokin
chemokin
product
bec
among
interferon
tumor
necrosi
factor
alpha
interleukin
thymic
stromal
lymphopoietin
tslp
dendrit
cell
dc
compon
innat
immun
direct
secondari
lymphoid
organ
captur
viral
antigen
stimul
lymphoid
cell
protagonist
specif
immun
respons
asthma
patient
product
ifn
reduc
allow
greater
viral
replic
stimul
tslp
deviat
lymphoid
profil
helper
lymphocyt
promot
lower
antivir
respons
increas
allerg
inflamm
bronchial
hyperreact
increas
product
mucu
caus
bronchial
obstruct
asthma
exacerb
asthma
base
criteria
castrorodriguez
children
younger
year
global
initi
asthma
gina
criteria
older
immunofluoresc
pcr
perform
nasopharyng
secret
children
show
posit
rate
virus
gener
hrv
hrsv
frequent
identifi
type
also
dual
detect
involv
analyz
virus
frequenc
viral
posit
immunofluoresc
higher
children
asthma
control
group
wheez
children
without
asthma
hrv
includ
studi
iflu
pflu
hadv
frequent
identifi
viru
group
asthma
patient
japan
respiratori
virus
detect
multiplex
pcr
children
exacerb
asthma
mean
age
month
hrsv
relat
singl
episod
wheez
p
hrv
frequent
observ
patient
histori
asthma
p
group
french
children
exacerb
treat
home
compar
stabl
asthmat
children
immunofluoresc
pcr
serolog
virus
mycoplasma
pneumonia
chlamydophila
pneumonia
detect
pathogen
sampl
significantli
higher
frequenc
case
control
viral
detect
test
posit
case
hrv
common
case
serolog
test
posit
atyp
pathogen
anoth
seri
children
exacerb
compar
stabl
children
studi
turkish
author
show
posit
case
control
rtpcr
reaction
hrv
commonli
found
viru
sampl
japan
children
acut
asthma
compar
stabl
asthmat
children
children
without
asthma
use
antigen
detect
kit
rtpcr
respiratori
virus
detect
nasal
aspir
sampl
exacerb
asthmat
children
hrv
common
parallel
assess
inflammatori
marker
show
signific
elev
p
interleukin
serum
nasal
aspir
patient
exacerb
well
increas
serum
eosinophil
cation
protein
ecp
level
p
flu
although
less
frequent
associ
episod
appear
respons
increas
morbid
patient
underli
chronic
diseas
includ
asthma
children
age
year
admit
diagnosi
infect
fluva
b
unit
state
asthma
patient
complic
significantli
associ
fluva
p
virus
assess
popul
anoth
studi
compar
exacerb
children
treat
hospit
n
treat
home
n
immunofluoresc
flu
hadv
hrsv
piv
perform
well
pcr
bocaviru
rate
viral
detect
obtain
differ
observ
regard
viral
profil
inpati
outpati
frequent
observ
virus
rsv
bocaviru
hrv
includ
viral
panel
studi
group
australian
children
age
year
nasal
secret
collect
three
period
compar
control
group
nonasthmat
children
upper
respiratori
tract
infect
urti
period
anoth
group
children
control
asthma
assess
routin
consult
hrv
hmpv
screen
rtpcr
panel
seven
virus
fluva
b
hadv
hrsv
studi
immunofluoresc
hrv
infect
account
urti
nonasthmat
children
coinfect
common
especi
hrsv
especi
children
younger
year
children
symptomat
asthma
highest
rate
hrv
infect
vs
among
children
final
children
control
asthma
lowest
rate
hrv
identif
vs
studi
conduct
aim
identif
hrv
exacerb
asthmat
patient
rtpcr
found
overal
frequenc
viral
identif
respect
first
studi
use
group
comparison
consist
stabl
asthma
patient
identif
rate
lower
case
group
studi
found
greater
associ
exacerb
presenc
hrv
c
anoth
import
issu
complex
associ
virus
asthma
relat
intens
associ
exacerb
viral
infect
sens
sever
studi
present
inconclus
result
although
hrv
associ
increas
sever
wors
respons
treatment
associ
viral
infect
acut
asthma
sever
evalu
children
age
year
posit
rate
presenc
viru
observ
direct
immunofluoresc
dif
multiplex
pcr
hrv
detect
case
type
c
observ
half
case
associ
greater
sever
fiftyeight
asthmat
children
age
year
monitor
period
five
week
april
septemb
nasal
lavag
sampl
collect
weekli
multiplex
pcr
analysi
addit
symptom
diari
peak
expiratori
flow
note
rescu
medic
use
viru
detect
specimen
hrv
identifi
posit
sampl
associ
greater
symptom
sever
nonetheless
viral
test
multiplex
pcr
pathogen
children
exacerb
asthma
compar
control
asthma
patient
perform
hong
kong
show
associ
presenc
viru
exacerb
sever
one
viru
identifi
case
detect
gener
associ
exacerb
ci
p
analyz
individu
viru
associ
exacerb
although
hrv
frequent
identifi
exacerb
control
asthma
patient
signific
differ
p
nasopharyng
aspir
sampl
asthmat
children
age
year
collect
episod
exacerb
refer
viral
identif
pcr
posit
rate
frequent
observ
hrv
follow
hrsv
associ
exacerb
sever
studi
compar
respons
treatment
bronchodil
exacerb
children
viral
respiratori
infect
symptom
n
group
without
symptom
n
mean
age
year
exacerb
sever
differ
group
children
viral
symptom
poor
respons
bronchodil
requir
dose
betaagonist
hour
viral
screen
conduct
case
hrv
frequent
found
viru
anoth
studi
exacerb
children
treat
hospit
compar
asymptomat
adult
multiplex
pcr
reaction
eight
respiratori
virus
monoplex
pct
enteroviru
hrv
bocaviru
detect
presenc
respiratori
virus
case
hrv
frequent
observ
viru
genotyp
show
higher
frequenc
type
c
hrv
associ
type
show
wors
clinic
outcom
asthma
exacerb
season
distribut
occur
cyclic
adult
children
explain
viral
circul
pattern
chang
level
pollut
aeroallergen
one
exampl
occur
temper
countri
higher
rate
occurr
like
observ
fall
spring
among
schoolchildren
combin
factor
may
explain
phenomenon
increas
circul
hrv
late
summer
earli
autumn
increas
circul
pollut
aeroallergen
return
school
summer
vacat
influenc
return
school
activ
may
explain
lower
adher
mainten
treatment
vacat
period
circul
virus
report
countri
northern
hemispher
especi
hrsv
autumnwint
flu
winter
fall
spring
brazil
data
viral
circul
collect
brazilian
system
epidemiolog
surveil
flu
virus
counterpart
period
sampl
obtain
nasopharyng
swab
patient
differ
sentinel
unit
distribut
throughout
countri
analyz
immunofluoresc
show
predomin
fluv
hrsv
circul
throughout
year
peak
latter
march
june
may
august
fluv
data
locat
concern
movement
hrv
brazil
publish
data
regard
season
exacerb
found
make
parallel
viru
circul
occurr
exacerb
author
analyz
data
obtain
studi
studi
conduct
feder
district
observ
higher
frequenc
month
march
still
midwest
region
state
increas
frequenc
respiratori
symptom
specifi
asthma
observ
winter
observ
regard
distribut
occurr
asthma
state
mina
gerai
also
show
higher
concentr
fallwint
may
juli
indic
predomin
respiratori
andor
asthma
symptom
brazilian
fallwint
season
addit
season
variat
viru
factor
involv
genesi
asthma
exacerb
may
explain
variat
aeroallergen
pollut
also
vari
throughout
differ
season
like
combin
factor
result
observ
season
peak
exacerb
month
april
year
studi
conduct
korea
aim
monitor
viral
infect
identifi
sensit
aeroallergen
children
acut
asthma
diagnosi
cold
whose
mean
age
year
children
allerg
sensit
present
number
viral
infect
symptom
nonsensit
anoth
studi
conduct
manchest
england
children
hospit
exacerb
compar
children
stabl
asthma
children
hospit
nonrespiratori
diseas
author
conclud
associ
viral
infect
allergen
exposur
increas
risk
hospit
admiss
brazil
camara
et
al
investig
role
viral
infect
sensit
exposur
aeroallergen
risk
factor
wheez
children
age
year
younger
year
frequenc
viral
posit
significantli
higher
case
control
older
children
signific
differ
case
posit
control
conclud
children
younger
year
risk
factor
associ
wheez
viral
infect
famili
histori
atopi
among
older
children
sensit
inhal
allergen
import
event
onset
crise
effect
air
pollut
usual
disregard
presenc
virus
allergen
howev
evid
acut
exposur
specif
pollut
may
contribut
symptom
sever
exacerb
instanc
cigarett
smoke
induc
model
noneosinophil
inflamm
rel
resist
corticosteroid
passiv
smoke
quit
common
home
asthmat
children
caus
neg
impact
diseas
control
scotland
legisl
ban
smoke
public
place
reduc
hospit
asthma
pollut
appear
contribut
asthma
exacerb
result
combust
natur
ga
engin
oil
nitrogen
dioxid
children
spend
time
outsid
breath
greater
amount
pollut
per
kilogram
weight
compar
adult
increas
level
associ
sever
virusinduc
exacerb
emphas
potenti
synerg
two
inflammatori
stimuli
moreov
control
exposur
asthma
patient
demonstr
increas
respons
inhal
allergen
cohort
asthmat
children
age
year
monitor
symptom
measur
peak
expiratori
flow
measur
exposur
presenc
viru
nasal
secret
period
month
one
virus
detect
report
episod
respiratori
symptom
demonstr
exposur
high
concentr
week
onset
viral
respiratori
infect
relat
exacerb
sever
longitudin
studi
conduct
unit
state
measur
exposur
cigarett
smoke
children
asthma
subset
period
nine
month
demonstr
increas
symptom
expos
among
nonatop
children
rel
risk
ci
associ
symptom
increas
cigarett
smoke
exposur
two
crosssect
studi
compar
children
expos
differ
level
cigarett
smoke
show
expos
high
level
higher
symptom
score
p
nocturn
symptom
ci
need
relief
p
control
p
medic
studi
children
age
year
random
intervent
environment
educ
guidelin
aim
reduc
exposur
show
reduct
exposur
group
receiv
instruct
period
month
intervent
group
fewer
day
symptom
p
one
year
followup
addit
decreas
level
dust
mite
dermatophagoid
pteronyssinu
dermatophagoid
farina
cockroach
antigen
home
environ
fungal
sensit
preval
children
asthma
although
studi
address
issu
compar
studi
relat
dust
mite
one
studi
demonstr
children
posit
skin
test
fungi
day
symptom
compar
neg
test
vs
two
week
p
studi
period
fungi
grown
intraand
extradomest
environ
increas
exposur
fungi
associ
increas
day
symptom
unschedul
physician
visit
asthma
preponder
viru
particip
among
infecti
agent
exacerb
make
indiscrimin
prescript
antibiot
situat
pointless
case
previou
studi
suggest
chest
radiographi
improperli
unnecessarili
use
children
adult
acut
asthma
treat
emerg
room
due
alter
usual
found
patient
asthmat
crise
hyperinsuffl
fluid
extravas
atelectasi
associ
hypoxemia
misinterpret
find
sign
pneumonia
common
consequ
unnecessari
prescript
antibiot
multicent
studi
asthmat
patient
treat
emerg
room
evalu
request
addit
test
case
chest
radiographi
blood
test
sever
ill
patient
year
comorbid
exclud
total
children
underw
addit
test
chest
radiographi
blood
test
exclud
febril
hypox
patient
still
subject
least
one
exam
despit
lack
brazilian
data
routin
pediatr
emerg
care
servic
countri
appear
adher
rule
order
prevent
dissemin
viral
agent
due
high
capac
viral
spread
droplet
fomit
hand
wash
use
respiratori
mask
simpl
strategi
proven
effect
stay
away
situat
favor
cluster
peopl
period
increas
viral
circul
recommend
although
studi
prove
effect
strategi
use
substanc
herbal
prepar
includ
echinacea
vitamin
c
evalu
doubleblind
placebocontrol
studi
fail
demonstr
benefit
prevent
viral
infect
vaccin
effect
way
control
diseas
caus
virus
case
respiratori
virus
vaccin
avail
flu
although
ongo
studi
develop
vaccin
respiratori
virus
especi
hrv
howev
great
antigen
divers
hinder
research
success
recent
studi
tri
establish
adequ
antigen
target
viral
structur
specif
rsv
immunoglobulin
success
use
reduc
hospit
viral
bronchiol
new
perspect
treatment
exacerb
trigger
viral
infect
emerg
studi
direct
synthet
agonist
receptor
agonist
among
other
specif
treatment
respiratori
virus
antivir
success
use
case
flu
infect
amantadin
rimantadin
oseltamivir
phosphat
zanamivir
latter
indic
patient
asthma
ribavirin
indic
treatment
sever
infect
caus
rsv
antivir
agent
studi
yet
approv
clinic
use
pleconaril
vapendavir
pirodavir
rupintrivir
glucocorticoid
potent
antiinflammatori
effect
success
use
mainten
treatment
patient
persist
asthma
control
inflamm
prevent
exacerb
studi
assess
effect
virusinduc
asthma
suppress
releas
proinflammatori
mediat
induc
hrv
infect
vitro
bronchial
epitheli
cell
well
reduct
factor
associ
remodel
achiev
use
budesonid
vitro
studi
document
action
corticosteroid
alon
combin
bronchodil
leukotrien
antagonist
reduc
releas
sever
inflammatori
molecul
potenti
modul
deleteri
effect
virus
asthmat
popul
despit
proven
benefit
inhal
corticosteroid
control
asthma
trigger
multipl
factor
action
virusinduc
exacerb
unclear
use
lowtomoder
dose
inhal
corticosteroid
mainten
therapi
prevent
intermitt
viralinduc
wheez
howev
better
result
obtain
intermitt
use
inhal
corticosteroid
high
dose
use
viral
detect
techniqu
high
sensit
specif
increas
identif
respiratori
virus
children
asthma
exacerb
direct
indirect
immunofluoresc
reaction
still
great
practic
import
detect
panel
seven
virus
fluva
b
hadv
hrsv
afford
fast
method
good
sensit
especi
children
current
use
brazilian
ministri
health
screen
respiratori
virus
diagnosi
sever
acut
flulik
ill
flulik
ill
sentinel
unit
techniqu
nucleic
acid
amplif
rtpcr
expens
sensit
thu
use
research
brazilian
ministri
health
identif
genotyp
flu
furthermor
allow
identif
virus
signific
clinic
epidemiolog
import
hrv
bocaviru
identifi
immunofluoresc
method
use
obtain
sampl
worth
mention
controversi
issu
nasopharyng
swab
viral
research
although
use
consolid
bacteri
infect
pneumonia
aureu
role
viral
infect
still
deserv
consider
author
agre
practic
point
view
feasibl
elimin
use
suction
system
probe
special
train
compar
aspir
lavag
sampl
howev
advanc
technolog
flock
swab
provid
best
captur
releas
cell
therefor
viru
equival
aspir
term
sampl
qualiti
nevertheless
swab
routin
use
servic
research
brazil
regard
associ
viral
infect
asthma
exacerb
wide
variat
observ
concern
method
studi
assess
viral
infect
exacerb
asthmat
children
studi
includ
review
instanc
sampl
size
vari
case
age
rang
year
find
import
given
difficulti
defin
asthma
children
younger
year
consid
case
select
moreov
known
consider
differ
age
group
preval
virus
hrsv
regard
method
respiratori
secret
collect
includ
studi
uniform
mean
collect
aspir
use
studi
swab
flock
swab
use
wide
variat
regard
detect
method
relat
outcom
addit
differ
sampl
collect
studi
crosssect
allow
establish
causeeffect
associ
viral
infect
onset
exacerb
suggest
associ
relat
factor
known
associ
uncontrol
asthma
allergen
irrit
studi
includ
variabl
evalu
inflammatori
process
typic
asthma
associ
viral
respiratori
infect
tendenc
greater
sever
durat
well
poorer
respons
convent
treatment
acut
episod
involv
mechan
still
need
fulli
elucid
evidenc
synergist
effect
viral
infect
allerg
airway
inflamm
pathogenesi
exacerb
anoth
pertin
issu
role
inhal
corticosteroid
attenu
inflamm
trigger
viru
also
seldom
mention
studi
action
control
reduct
morbid
associ
asthma
well
establish
still
controversi
subject
regard
prevent
viralinduc
wheez
effect
inflammatori
process
trigger
viru
demonstr
vitro
studi
studi
evalu
clinic
benefit
yet
reach
conclus
result
regardless
direct
virusallergen
interact
present
find
strongli
suggest
adequ
strategi
prevent
virusinduc
exacerb
focu
two
cours
name
improv
antivir
respons
reduct
allerg
sensit
inflamm
latter
achiev
appropri
treatment
asthma
patient
risk
medic
reduc
airway
inflamm
convers
prevent
measur
viral
infect
acquisit
time
diagnosi
allow
proper
manag
exacerb
reduct
number
hospit
unnecessari
addit
test
especi
children
febril
time
assess
associ
viral
infect
asthma
childhood
still
sever
point
need
clarif
especi
actual
role
virus
trigger
exacerb
inhal
corticosteroid
attenu
de
amparo
pesquisa
estado
de
n
author
declar
conflict
interest
